Bryant Furlow

Researchers used multiplexed IHC to identify steroid-sensitive GI aGVHD vs steroid-refractory GI aGVHD, a life-threatening late effect of HCT.

Research results demonstrate that substance use and psychiatric disorders have a negative effect on mortality among veterans with AML receiving venetoclax.

Researchers sought to determine which geriatric assessment tools were optimal for predicting chemotherapy toxicity events in older patients with advanced lymphoma.

The MASCC Oncodermatology Study Group published a long anticipated, evidence-based set of recommendations for acute radiation dermatitis prevention and management.

Amivantamab plus lazertinib represents a new standard of care for treatment-naive, EGFR-mutant advanced NSCLC, according to Dr Byoung Chul Cho.

Patients with previously treated, advanced NSCLC had longer progression-free survival with Dato-DXd than with docetaxel in a phase 3 study.

Treatment with ¹⁷⁷Lu-PSMA-617 is more effective than a change in ARPI therapy for taxane-naïve patients with PSMA+ mCRPC, data suggest.

Researchers report on modifications to a treatment protocol for pediatric patients with ALL, improving outcomes for children with IKZF1-deleted ALL, Down syndrome, ETV6::RUNX1, and poor prednisone response.

Reliance on radiation oncology is declining as new, targeted, and immunotherapies with fewer adverse effects proliferate, and as advances in imaging allow cancer diagnosis at earlier stages for some patients.

Hypofractionated radiotherapy can be safe and effective for patients with locally advanced head and neck squamous cell carcinoma, a phase 3 trial suggests.